Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients after FAC Chemotherapy: A Carvedilol Trial. International Journal of Integrated Health Sciences, v. 12, n. 1, p. 55–64, 30 Mar.2024.